Marc D Beer's Net Worth
$14.6 Million
Who is Marc D Beer?
Marc D Beer has an estimated net worth of $14.6 Million. This is based on reported shares across multiple companies, which include VIACELL INC, Minerva Neurosciences, Inc., biote Corp., and Aegerion Pharmaceuticals, Inc..
SEC CIK
Marc D Beer's CIK is 0001314575
Past Insider Trading and Trends
2022 was Marc D Beer's most active year for acquiring shares with 8 total transactions. Marc D Beer's most active month to acquire stocks was the month of April. 2018 was Marc D Beer's most active year for disposing of shares, totalling 5 transactions. Marc D Beer's most active month to dispose stocks was the month of December. 2017 saw Marc D Beer paying a total of $405,750.00 for 62,500 shares, this is the most they've acquired in one year. In 2023 Marc D Beer cashed out on 2,596,152 shares for a total of $2,596,152.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VIACELL INC No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 700K |
$0.54 | $380,000.00 | 700K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Minerva Neurosciences, Inc. (NERV) Snapshot price: $11.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 50K |
$8.12 | $405,750.00 | 50K |
Mar 17 - Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
biote Corp. (BTMD) Snapshot price: $4.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| -22.58% | -865.38K |
$3.00 | -$2,596,152.00 | 2.97M |
Jan 6 - Jan 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4/A
| +20.59% | 654.39K |
—
|
—
| 3.83M |
May 26
| |||
Form 4
| +120.58% | 3.83M |
—
|
—
| 7.01M |
May 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aegerion Pharmaceuticals, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||